Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer

11 Jul 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glutathione Transferases and Polymorphisms
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18622615
DOI: 10.1007/s00280-008-0791-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancerPMID 18622615Read ↗

Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancerSemantic proximity Read ↗

Ovarian Cancer—Insights into Platinum Resistance and Overcoming ItSemantic proximity Read ↗

Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancerSemantic proximity Read ↗

SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene TargetsSemantic proximity Read ↗

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian CancersSemantic proximity Read ↗

Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian TumorsSemantic proximity Read ↗

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian CancerSemantic proximity Read ↗

Glutathione Transferase P1: Potential Therapeutic Target in Ovarian CancerSemantic proximity Read ↗

Cisplatin resistance: Preclinical findings and clinical implicationsSemantic proximity Read ↗

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.